Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02619773
Other study ID # 2-15-10-001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2015
Est. completion date December 2018

Study information

Verified date January 2019
Source Gundersen Lutheran Medical Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Infections at the site of surgical incisions (SSIs) are the most common infection among surgical patients. Although all patients undergoing surgical procedures are at risk for developing SSIs, colorectal surgery has had consistently had high rates of SSIs, ranging from 3-45%. These infections can increase the length of hospital stay, and increase the rate of readmissions and costs.

Further research is needed to study the effects of mupirocin in general surgery. A recent study compared colorectal SSI rates between mupirocin and standard gauze surgical dressings. The results of this show that mupirocin has the greatest effect on reducing SSI rate when compared to standard gauze dressings. However, these studies have not been performed in the United States and have only been studied on a very specific patient population.

The purpose of this study is to assess the rate of infections at the surgical incision after colorectal surgery when a mupirocin dressing is placed versus a standard gauze dressing without mupirocin.


Description:

Surgical site infections (SSIs) are the most common nosocomial infection among surgical patients and are the third most common nosocomial infection among all hospitalized patients.1 Although all patients undergoing surgical procedures are at risk for developing SSIs, colorectal surgery has consistently had high rates of surgical site infections, ranging from 3-45%. Numerous studies have shown the adverse effects of SSIs, including increased length of hospital stay, morbidity, mortality, readmissions and costs. In a recent study analyzing various surgical procedures, including colorectal operations, surgical site infection was found to be the number one cause of unplanned readmission.

Studies have been performed showing that intranasal mupirocin may have a role in reduction of SSI in cardiac and orthopedic surgery. However, there has been minimal investigation on the effects of topical mupirocin in general surgery. A recent study from Spain compared colorectal SSI rates between mupirocin dressings, silver-impregnated dressings, and standard gauze surgical dressings. The results of this show that mupirocin has the greatest effect on reducing SSI rate when compared to standard gauze and silver-impregnated dressings. However, these studies have not been performed in the United States and have only been studied on open, colorectal oncologic surgery.

The aim of this study is to compare mupirocin dressings to standard surgical dressings and their respective SSI rates at a United States community hospital in patients undergoing elective open and minimally invasive colorectal surgery.

A single-center prospective, randomized study will be performed. Patients who will undergo elective colorectal surgery and consent to participate will be randomized (1:1) to one of the following 2 treatment groups:

1. Island dressings until postoperative day (POD) #2 (which is current practice at Gundersen Health System)

2. Mupirocin + island dressing until POD#5 Analysis of outcomes will include rate of SSI, and 30-day morbidity and mortality.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Elective Colorectal surgery

- Open and minimally invasive cases

- Partial and total Colon resections, Abdominoperineal resection, Low anterior resections, Creation/takedown of colostomy, abdominal procedures for prolapse

Exclusion Criteria:

- Patients with known allergies to mupirocin

- Cases in which the skin was intentionally left open at the end of surgery (secondary closure technique)

- Women who are pregnant or planning to become pregnant

Study Design


Intervention

Procedure:
mupirocin ointment
Mupirocin ointment will be applied after skin closure. A standard island dressing will be placed over the incision.

Locations

Country Name City State
United States Gundersen Lutheran Health System La Crosse Wisconsin

Sponsors (2)

Lead Sponsor Collaborator
Gundersen Lutheran Medical Foundation Gundersen Lutheran Health System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Surgical Site Infection Surgical site infection defined per ACS NSQIP criteria within 30 days postoperative
See also
  Status Clinical Trial Phase
Completed NCT04969302 - Examination of the Effect of Skin Antisepsis With Pre-heated Povidone Iodine on Surgical Site Infections: A Quasi-Experimental Study N/A
Completed NCT02253069 - PHMB-based Antiseptic Use in Full-thickness Surgical Wounds N/A
Completed NCT01472549 - The Skin Prep Study N/A
Completed NCT03685604 - PVP Iodine vs Chlorhexidine in Alcohol for Disinfection of the Surgical Site Phase 4
Not yet recruiting NCT02503904 - Tumescent Antibiotic Delivery for Prevention of Surgical Site Infection Phase 2/Phase 3
Completed NCT01888367 - Safety, Efficacy and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery Phase 2
Completed NCT01425697 - Eliminate Risk of Cardiac Surgical Site Events N/A
Terminated NCT02799667 - Do Single Use Negative Pressure Dressings Reduce Wound Complications in Obese Women After Cesarean Delivery N/A
Recruiting NCT02436395 - Povidone-iodine and the Normal Saline Cleaning the Incision for the SSIs N/A
Active, not recruiting NCT03402945 - Prevention of Infections in Cardiac Surgery (PICS) Prevena Study Phase 4
Withdrawn NCT02666365 - Continuous v Bolus Infusion of Cefazolin During Ventral Hernia Repair Phase 4
Completed NCT01971138 - Review of Surgical Site Infection Registration Routine at Surgery Departments in Sweden and Validation of One of the Used Routines N/A
Completed NCT01949935 - Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting Phase 3
Completed NCT01138852 - Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section Phase 4
Recruiting NCT06378359 - Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
Not yet recruiting NCT02012517 - Antibiotic Prophylaxis in Prosthetic Breast Reconstructions Phase 4
Completed NCT03686553 - St. Barbara Specialised Regional Hospital No. 5: Surveillance of Healthcare-Associated Infections
Completed NCT01916733 - A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study N/A
Not yet recruiting NCT06043414 - Barbed Suture vs Non-Barbed Closure for Emergency Exploratory Laparotomy RCT N/A
Completed NCT05090657 - Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures Phase 2